Tenvir-EM Emtricitabine and Tenofovir Disoproxil Fumarate

2000 INR

Get a Price/Quote

Product Details:

Supply Ability : 10000 Box Per Month
Click to view more
Share Your Product:

Request To Call Back Send Inquiry

Price And Quantity

Minimum Order Quantity 1 Box
Price 2000 INR

Trade Information

FOB Port Delhi, Mumbai
Payment Terms Letter of Credit (L/C), Letter of Credit at Sight (Sight L/C), Paypal, Western Union, Telegraphic Transfer (T/T), Cash in Advance (CID), Cheque, Cash Advance (CA)
Supply Ability 10000 Box Per Month
Delivery Time 7 Days
Packaging Details 30 Tablets per bottle
Main Export Market(s) Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa, Asia
Main Domestic Market All India

Product Description

TENMAC-EM

Each tablet contains:

Tenofovir Disoproxil Fumarate 300 mg
Emtricitabine 200mg

CONTRAINDICATIONS:

Do not use TENMAC-EM for pre-exposure prophylaxis in individuals with unknown or positive HIV-1 status. TENMAC-EM should be used in HIV-infected patients only in combination with other anti-retroviral agents.

SIDE EFFECTS:

In HIV1 infected patients, the most common adverse reactions (incidence greater than or equal to 10%) are diarrhea, nausea, fatigue, headache, dizziness, depression, insomnia, abnormal dreams, and rash. In HIV-1 uninfected individuals in PrEP trials, adverse reactions that were reported by more than 2% of TENMAC-EM subjects and more frequently than by placebo subjects were headache, abdominal pain and weight decreased.

PACKING:

HDPE Bottle packs of 30 tablets and packed in a unit carton along with package insert.

SHELF LIFE AND STORAGE:

24 months from the date of manufacturing, below 30C.